Publications

European journal of cancer care

Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7).

01-01-2018

Cancer chemotherapy and pharmacology

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a ¹⁴C-microtracer and therapeutic dose in cancer patients.

01-01-2018

International journal of colorectal disease

Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer.

01-01-2018

International journal of radiation oncology, biology, physics

Radiation Oncology in The Netherlands.

01-01-2018

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer.

01-01-2018

Nuclear medicine communications

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

01-01-2018

The international journal of biochemistry & cell biology

Glycerophosphodiesterase GDE2/GDPD5 affects pancreas differentiation in zebrafish.

01-01-2018

The British journal of surgery

Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.

01-01-2018

Laboratory investigation; a journal of technical methods and pathology

Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.

01-01-2018

British journal of cancer

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

01-01-2018

Trends in molecular medicine

Is It Our Duty To Hunt for Pathogenic Mutations?

01-01-2018

Clinical cancer research : an official journal of the American Association for Cancer Research

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.

01-01-2018

Life science alliance

CHRAC/ACF contribute to the repressive ground state of chromatin.

01-01-2018

Expert review of quality of life in cancer care

Cancer symptom response as an oncology clinical trial end point.

01-01-2018

Annals of surgical oncology

Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?

01-01-2018

Oncotarget

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

26-12-2017

PloS one

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

22-12-2017

PloS one

Optimal endobronchial tool sizes for targeting lung lesions based on 3D modeling.

21-12-2017

European heart journal

CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice.

21-12-2017

Annals of internal medicine

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

19-12-2017

Development (Cambridge, England)

Knockout of the Arp2/3 complex in epidermis causes a psoriasis-like disease hallmarked by hyperactivation of transcription factor Nrf2.

15-12-2017

Science (New York, N.Y.)

Vasohibins encode tubulin detyrosinating activity.

15-12-2017

The EMBO journal

Cohesin: building loops, but not compartments.

15-12-2017

eLife

The Human Cell Atlas.

05-12-2017

Oncotarget

Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel.

05-12-2017

Journal of the National Cancer Institute

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.

01-12-2017

JAMA oncology

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

01-12-2017

Annals of oncology : official journal of the European Society for Medical Oncology

LAG-3: another brake to release in breast cancer?

01-12-2017

Annals of oncology : official journal of the European Society for Medical Oncology

DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update.

01-12-2017

Clinical and translational radiation oncology

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy.

01-12-2017

European journal of nuclear medicine and molecular imaging

Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.

01-12-2017

Journal of cancer survivorship : research and practice

Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice.

01-12-2017

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise.

01-12-2017

Cancer chemotherapy and pharmacology

Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.

01-12-2017

International journal of epidemiology

Body mass index and breast cancer survival: a Mendelian randomization analysis.

01-12-2017

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best Biomarker.

01-12-2017

Annals of oncology : official journal of the European Society for Medical Oncology

Molecular Tumor Boards: current practice and future needs.

01-12-2017

Investigational new drugs

Human mass balance study and metabolite profiling of ¹⁴C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer.

01-12-2017

JAMA oncology

Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study.

01-12-2017

Oral oncology

Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.

01-12-2017

Thrombosis and haemostasis

Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry.

01-12-2017

Hepatology (Baltimore, Md.)

In vivo veritas: Finding novel genes involved in liver cancer through in vivo genetic screens.

01-12-2017

Breast cancer research and treatment

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.

01-12-2017

Journal of surgical oncology

Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.

01-12-2017

The oncologist

A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.

01-12-2017

International wound journal

Assessing and comparing the quality of wound centres: a literature review and benchmarking pilot.

01-12-2017

Reproductive biomedicine online

Low oocyte yield during IVF treatment and the risk of a trisomic pregnancy.

01-12-2017

Annals of surgical oncology

In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care.

01-12-2017

Annals of surgical oncology

Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.

01-12-2017

Nature genetics

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

01-12-2017

Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7).

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients.

Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer.

Radiation Oncology in The Netherlands.

Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer.

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

Glycerophosphodiesterase GDE2/GDPD5 affects pancreas differentiation in zebrafish.

Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.

Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

Is It Our Duty To Hunt for Pathogenic Mutations?

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.

CHRAC/ACF contribute to the repressive ground state of chromatin.

Cancer symptom response as an oncology clinical trial end point.

Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Optimal endobronchial tool sizes for targeting lung lesions based on 3D modeling.

CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice.

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

Knockout of the Arp2/3 complex in epidermis causes a psoriasis-like disease hallmarked by hyperactivation of transcription factor Nrf2.

Vasohibins encode tubulin detyrosinating activity.

Cohesin: building loops, but not compartments.

The Human Cell Atlas.

Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel.

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

LAG-3: another brake to release in breast cancer?

DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update.

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy.

Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.

Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice.

Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise.

Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best Biomarker.

Molecular Tumor Boards: current practice and future needs.

Human mass balance study and metabolite profiling of 14C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer.

Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study.

Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.

Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry.

In vivo veritas: Finding novel genes involved in liver cancer through in vivo genetic screens.

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.

Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.

A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.

Assessing and comparing the quality of wound centres: a literature review and benchmarking pilot.

Low oocyte yield during IVF treatment and the risk of a trisomic pregnancy.

In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care.

Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

This site uses cookies

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a ¹⁴C-microtracer and therapeutic dose in cancer patients.

Human mass balance study and metabolite profiling of ¹⁴C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer.